Rapport Therapeutics, Inc. Common Stock
RAPP · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $251,359 | $55,067 | $57,604 | $56,805 |
| Short-Term Investments | $261,667 | $205,380 | $227,778 | $248,475 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $7,633 | $9,795 | $5,586 | $4,522 |
| Total Curr. Assets | $520,659 | $270,242 | $290,968 | $309,802 |
| Property Plant & Equip (Net) | $13,596 | $14,219 | $10,874 | $4,971 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $1,068 | $1,034 | $211 | $160 |
| Total NC Assets | $14,664 | $15,253 | $11,085 | $5,131 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $535,323 | $285,495 | $302,053 | $314,933 |
| Liabilities | – | – | – | – |
| Payables | $3,235 | $3,176 | $2,139 | $1,954 |
| Short-Term Debt | $2,482 | $1,759 | $1,008 | $737 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $8,599 | $6,944 | $6,236 | $6,076 |
| Total Curr. Liab. | $14,316 | $11,879 | $9,383 | $8,767 |
| LT Debt | $9,390 | $10,104 | $6,834 | $739 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $9,390 | $10,104 | $6,834 | $739 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $11,863 | $7,842 | $1,476 |
| Total Liabilities | $23,706 | $21,983 | $16,217 | $9,506 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $48 | $37 | $37 | $37 |
| Retained Earnings | -$201,465 | -$174,540 | -$147,808 | -$123,745 |
| AOCI | $145 | -$76 | -$95 | -$522 |
| Other Equity | $712,889 | $438,091 | $433,702 | $429,657 |
| Total Equity | $511,617 | $263,512 | $285,836 | $305,427 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $535,323 | $285,495 | $302,053 | $314,933 |
| Net Debt | -$239,487 | -$43,204 | -$49,762 | -$55,329 |